Mumbai-based in-vitro diagnostic Company Transasia Bio-Medicals has been ranked as one of the top 500 most valuable companies in India.

This annual list was recently released by Hurun India in coordination with Burgundy Private and Axis Bank's Private Banking Business.

Transasia features in the Top 500 list at the #354 position with an estimated value of Rs 8,900 crore.

“Transasia is honoured to be featured in the 2021 list. We are proud to be recognized and featured alongside so many other inspiring, innovative companies that value a workplace culture built on integrity, trust, and compassion,” cited Suresh Vazirani, Founder Chairman, Transasia-Erba Group of Companies.

Through its state of the art R&D centres in India, Europe and USA, Transasia has developed world-class technologies for a wide range of disease diagnosis and solutions in Clinical Chemistry, Hematology, Immunology, Diabetes Management, Urinalysis, Coagulation, Critical Care and Molecular Diagnostics.

The companies included in the list of 500 most valuable companies are ranked according to their value, defined as market capitalisation for listed companies and valuations for non-listed companies.